Skip to main content

Table 1 Clinical characteristics of HFrEF patients and control subjects

From: Primary skeletal muscle myoblasts from chronic heart failure patients exhibit loss of anti-inflammatory and proliferative activity

Characteristic

Controls n = 8

HFrEF n = 8

p-value

Age (years)

55 ± 1.8

53 ± 4.5

0.939

Gender (% male)

62.5 %

62.5 %

1.000

Weight (Kg)

83.1 ± 6.4

74.6 ± 6.8

0.367

BMI (Kg/m2)

27.0 ± 1.3

23.3 ± 1.7

0.088

LVEF (%)

N.A.

31.3 ± 6.0

N.A.

Total cholesterol (mmol/L)

5.02 ± 0.18

4.45 ± 0.51

0.469

HDL (mmol/L)

1.53 ± 0.15

1.25 ± 0.24

0.101

LDL (mmol/L)

3.05 ± 0.29

2.52 ± 0.42

0.363

Triglycerides (mmol/L)

1.00 ± 0.09

1.77 ± 0.17

0.003

Glucose (mmol/L)

4.75 ± 0.16

5.51 ± 0.39

0.151

Serum Creatinine (mmol/L)

76.91 ± 3.54

103.43 ± 17.68

0.279

hsCRP (mg/L)

<2.9

22.0 ± 11.3

0.007

  1. N, Number of subjects; HFrEF, Heart failure with reduced ejection fraction; BMI, Body mass index; LVEF, Left Ventricular Ejection fraction; HDL, High density lipoprotein; LDL, Low density lipoprotein; hsCRP, high sensitivity C-reactive protein. Significant p-values are highlighted in bold. Data are expressed as mean ± SEM